AI-Driven Test-Free Prediction of ICU Admission, Insulin Dependence, and Exocrine Dysfunction After Acute Pancreatitis.

IF 2.2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY
Pancreas Pub Date : 2026-11-01 Epub Date: 2026-07-01 DOI:10.1097/MPA.0000000000002697
Ishanu Chattopadhyay, Dmytro Onishchenko, Philip A Kern, Darwin L Conwell
{"title":"AI-Driven Test-Free Prediction of ICU Admission, Insulin Dependence, and Exocrine Dysfunction After Acute Pancreatitis.","authors":"Ishanu Chattopadhyay, Dmytro Onishchenko, Philip A Kern, Darwin L Conwell","doi":"10.1097/MPA.0000000000002697","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Acute pancreatitis (AP) has heterogeneous trajectories: some patients deteriorate rapidly and require ICU care, whereas others develop delayed sequelae such as exocrine pancreatic dysfunction (EPD) and pancreatogenic diabetes. Existing scoring systems are burdensome, not available at first presentation, and poorly suited for forecasting longer-term outcomes.</p><p><strong>Methods: </strong>Our AI platform operating exclusively on routinely collected EHR predicts 3 outcomes after a first recorded AP diagnosis: (1) ICU admission (same-day, within 1 wk, within 2 wk); (2) incident EPD; and (3) incident insulin dependence among patients without prior diabetes diagnosis or antihyperglycemic prescriptions. Models were trained and validated using a US administrative claims database comprising > 164 million individuals.</p><p><strong>Results: </strong>We demonstrate area under the receiver operating curves (AUCs) of 0.986 (same-day ICU), 0.933 (ICU within 1 wk), and 0.927 (ICU within 2 wk). For longer-term outcomes, AUCs were 0.913 (male) and 0.901 (female) for incident EPD, and 0.861 (male) and 0.884 (female) for incident insulin dependence. Established chronic pancreatitis risk factors (eg, obesity, tobacco dependence) are recovered with large effect sizes and high significance, supporting epidemiologic plausibility. Negative associations were consistent with etiologic subtypes, competing risks, and health care utilization patterns.</p><p><strong>Conclusions: </strong>Using only existing coded longitudinal history from a US administrative claims environment, ZeBRA enables simultaneous, test-free prediction of early deterioration and delayed pancreatic sequelae after AP, providing a scalable and interpretable basis for early risk stratification and targeted follow-up across the AP-chronic pancreatitis continuum. Broader clinical adoption will require external validation, especially in non-US health systems and data sets with different coding and care-delivery structures.</p>","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":" ","pages":"e1026-e1033"},"PeriodicalIF":2.2000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pancreas","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MPA.0000000000002697","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/1 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Acute pancreatitis (AP) has heterogeneous trajectories: some patients deteriorate rapidly and require ICU care, whereas others develop delayed sequelae such as exocrine pancreatic dysfunction (EPD) and pancreatogenic diabetes. Existing scoring systems are burdensome, not available at first presentation, and poorly suited for forecasting longer-term outcomes.

Methods: Our AI platform operating exclusively on routinely collected EHR predicts 3 outcomes after a first recorded AP diagnosis: (1) ICU admission (same-day, within 1 wk, within 2 wk); (2) incident EPD; and (3) incident insulin dependence among patients without prior diabetes diagnosis or antihyperglycemic prescriptions. Models were trained and validated using a US administrative claims database comprising > 164 million individuals.

Results: We demonstrate area under the receiver operating curves (AUCs) of 0.986 (same-day ICU), 0.933 (ICU within 1 wk), and 0.927 (ICU within 2 wk). For longer-term outcomes, AUCs were 0.913 (male) and 0.901 (female) for incident EPD, and 0.861 (male) and 0.884 (female) for incident insulin dependence. Established chronic pancreatitis risk factors (eg, obesity, tobacco dependence) are recovered with large effect sizes and high significance, supporting epidemiologic plausibility. Negative associations were consistent with etiologic subtypes, competing risks, and health care utilization patterns.

Conclusions: Using only existing coded longitudinal history from a US administrative claims environment, ZeBRA enables simultaneous, test-free prediction of early deterioration and delayed pancreatic sequelae after AP, providing a scalable and interpretable basis for early risk stratification and targeted follow-up across the AP-chronic pancreatitis continuum. Broader clinical adoption will require external validation, especially in non-US health systems and data sets with different coding and care-delivery structures.

ai驱动的无测试预测急性胰腺炎后ICU入院、胰岛素依赖和外分泌功能障碍。
目的:急性胰腺炎(AP)具有不同的发展轨迹:一些患者病情迅速恶化,需要ICU护理,而另一些患者则出现延迟的后遗症,如外分泌胰腺功能障碍(EPD)和胰源性糖尿病。现有的评分系统负担沉重,第一次展示时不可行,也不适合预测长期结果。方法:我们的人工智能平台仅在常规收集的电子病历上运行,预测首次记录AP诊断后的三个结果:(i) ICU入院(当天,1周内,2周内),(ii)发生EPD, (iii)没有糖尿病诊断或抗高血糖处方的患者发生胰岛素依赖。使用包含1.64亿人的美国行政索赔数据库对模型进行了训练和验证。结果:受试者工作曲线下面积(AUC)分别为0.986(当日ICU)、0.933(1周内ICU)和0.927(2周内ICU)。对于长期结果,EPD事件的auc分别为0.913(男性)和0.901(女性),胰岛素依赖事件的auc分别为0.861(男性)和0.884(女性)。已确定的慢性胰腺炎危险因素(如肥胖、烟草依赖)恢复具有大效应量和高显著性,支持流行病学上的合理性。负相关与病因亚型、竞争风险和医疗保健利用模式一致。结论:仅使用来自美国行政索赔环境的现有编码纵向历史,ZeBRA可以同时,无测试地预测AP后早期恶化和延迟的胰腺后遗症,为AP-慢性胰腺炎连续体的早期风险分层和靶向随访提供可扩展和可解释的基础。更广泛的临床应用需要外部验证,特别是在非美国。具有不同编码和保健提供结构的卫生系统和数据集。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pancreas
Pancreas 医学-胃肠肝病学
CiteScore
4.70
自引率
3.40%
发文量
289
审稿时长
1 months
期刊介绍: Pancreas provides a central forum for communication of original works involving both basic and clinical research on the exocrine and endocrine pancreas and their interrelationships and consequences in disease states. This multidisciplinary, international journal covers the whole spectrum of basic sciences, etiology, prevention, pathophysiology, diagnosis, and surgical and medical management of pancreatic diseases, including cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书